| Literature DB >> 35161335 |
Vanya Rangelov Kozhuharov1, Kalin Ivanov1, Stanislava Ivanova1.
Abstract
BACKGROUND: Higenamine is a β2 agonist of plant origin. The compound has been included in WADA's prohibited list since 2017. Higenamine may be detected in different plants and many food supplements of natural origin.Entities:
Keywords: Aconitum carmichaelii; Aristolochia brasiliensis; Asarum siebodii; Gnetum parvifolium; Nandina domestica; Nelumbo nucifera; Tinospora crispa; higenamine in plants
Year: 2022 PMID: 35161335 PMCID: PMC8838985 DOI: 10.3390/plants11030354
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Food supplements as a source of unintentional doping.
Figure 2Higenamine, epinephrine, norepinephrine, and catechol structures.
Figure 3S-(-)-higenamine and R-(+)-higenamine structures.
Figure 4PRISMA 2020 flow diagram for new systematic reviews, which includes database and register searches only.
Methods for identification and quantification of higenamine in plant extracts.
| Plant Name | Plant Part | Investigation Methods | Main Results | Reference |
|---|---|---|---|---|
|
| dried leaf and seed | QuEChERS LC–MS/MS | Higenamine was detected in dried lotus leaf, dried lotus seeds at a concentration of 9667.6 and 1183.8 μg/kg, respectively. | [ |
|
| plumule | UPLC–DAD | 21 alkaloids were identified, including higenamine. | [ |
|
| root of embryo | High-Performance Liquid Chromatography with a Fluorescent Chiral Tagging Reagent | [ | |
|
| seed, leaf stamen, plumule, receptacle, and rhizome node | UPLC and QToF-MS | Higenamine was detected in leaves and plumule | [ |
|
| root | Column chromatography | Higenamine was isolated from | [ |
| icELISA and HPLC. | Higenamine amounts detected: | [ | ||
| roots | 2.58 × 10−1–3.04 μg/g dry wt | |||
| fruit | 12.21 μg/g dry wt | |||
| leaf | 56.30 μg/g dry wt | |||
| root | 31.07 μg/g dry wt | |||
| fruit | 6.48 μg/g dry wt | |||
| root | HPLC | Aconitum extracts contained 8–19 μg/g of higenamine | [ | |
|
| root | LC coupled with MS/MS | Concentration of higenamine in different decoctions were: Bifupian 2.31 ± 0.11μg/g Heishunpian 3.03 ± 0.15 μg/g | [ |
|
| root | LC–MS/MS | 10 of the identified compounds, including quercetin, pseudoephedrine, ephedrine, | [ |
|
| lianas | NMR | 5 alkaloids were isolated, including higenamine | [ |
Studies of higenamine in human/mammals in various matrices.
| Study | Aim | Main Results | Ref. |
|---|---|---|---|
| The risk of adverse higenamine analytical findings following oral administration of | Detection of higenamine in urine samples | The concentration of higenamine in most urine sample groups exceeded the limit specified by WADA. | [ |
| Crude extract and purified components isolated from the stems of | Investigation into the mechanism of | Higenamine increased the left atrium’s contraction force. | [ |
| Hypotensive and cardio-chronotropic constituents of | Identifying the active components in | Salsolinol, tyramine, and higenamine acted via the adrenoreceptors, whereas uridine and adenosine acted via purinergic adenosine A2 and P2 receptors to decrease blood pressure. | [ |
| Counter effects of higenamine and coryneine, components of Aconite root, on acetylcholine release from motor nerve terminal in mice | Detection of higenamine counteraction on acetylcholine release. | Higenamine increases Ach release by activating β-adrenoreceptors. Coryneine depresses Ach release by acting on the motor nerve terminal. | [ |
| β2 -adrenoceptor-mediated tracheal relaxation induced by higenamine from | Identifying active components and mechanism of action on tracheal relaxation | Higenamine is major constituent of | [ |
| Biphasic tracheal relaxation induced by higenamine and nantenine from | Comparing the effects of crude extract, higenamine, and nantenine | Higenamine relaxes the trachea by β-adrenoceptor stimulation. | [ |
| Determining higenamine and coclaurine levels in human urine after the administration of a throat lozenge containing | Investigation of throat lozenge components and developing a mass-spectrometry method for quantifying higenamine and coclaurine in human urine. | The maximum concentrations of higenamine and coclaurine were 0.2−0.4 and 0.3−1.0 ng/mL. They did not exceed WADA’s criteria. | [ |
| Evaluation of anti-microbacterial activity of higenamine using | Investigation of anti-microbacterial effects of higenamine from | Higenamine was isolated from | [ |
| A triple combination strategy of UHPLC–MSn, hypolipidemic activity, and transcriptome sequencing to unveil the hypolipidemic mechanisms of | Screening of | 35 compounds were found in | [ |